Dr. Reddys Laboratories Ltd.

Dr Reddys Laboratories has reported results for quarter and year ended March 31, 2013.

The company’s net profit surged by 78.55% at Rs 378.15 crore for Q4FY13 as compared to Rs 211.79 crore in Q4FY12. Its total income increased by 19.51% to Rs 2451.27 crore in the quarter under review from Rs 2051.18 crore  in the corresponding quarter of the previous year.

On consolidated basis, company’s net profit surged by 66.59% at Rs 570.89 crore for Q4FY13 as compared to Rs 342.70 crore in Q4FY12. Its total income increased by 30.80% at Rs 3503.04 crore  in the quarter under review from Rs 2678.25 crore in the corresponding quarter of the previous year.

For the full year ended March 31, 2013, the company’s net profit jumped higher by 38.70% at Rs 1265.47 crore as against Rs 912.36 crore in the FY 12. Its total income 25.72% at Rs 8575.72 crore from the quarter under review as compared to Rs 6821.48 crore in corresponding quarter of the previous year.

On consolidated basis, the full year ended March 31, 2013, the group’s net profit grew by 17.63% at Rs 1677.62 crore as against Rs 1426.21 crore in the FY12. Its total income rose by 21.79% at Rs 11874.46 crore from the year as compared to Rs 9750.24 crore in previous fiscal.

The company’ board of directors of the company at its meeting held on May 14, 2013, has recommended a final dividend of Rs 15 (300%) per equity share of Rs 5 face value, for the financial year 2012-13.